EN DE
STOCK COMPARISON

Siegfried Holding vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Siegfried Holding (SFZN) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Siegfried Holding as the less overvalued of the two: Siegfried Holding trades at CHF 79.65 versus a fair value of CHF 52.72 (-34%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).
Siegfried Holding
SFZN.SW · CHF · Health Care
-34%
upside to fair value
overvalued
PriceCHF 79.65
Fair ValueCHF 52.72
Quality52/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-53%
upside to fair value
overvalued
Price¥54.62
Fair Value¥25.94
Quality66/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Siegfried HoldingJiangsu Hengrui Medicine Co
Valuation
19.0×P/E (TTM)43.6×
2.98×P/S (TTM)10.84×
3.51×P/B5.76×
13.7×EV/EBITDA33.0×
1.42×PEG0.93×
0.5%Dividend yield0.4%
CHF 0.40Dividend per share¥0.20
Profitability
13%Net margin25%
19%Operating margin32%
16%Return on equity15%
7%Return on assets9%
Growth
5%Revenue growth (YoY)13%
2.6%Avg. growth/yr (3Y)13.9%
9.5%Avg. growth/yr (5Y)2.5%
Balance & size
0.33×Debt / equity—
$4BMarket cap$52B
expensiveGrowth qualityhealthy

Siegfried Holding leads: 7 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Siegfried Holdingof which business quality 52 · market factors 39 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 46
ProfitabilityMargins and returns on capital today
48
63
Quality GrowthAre margins and returns improving?
43
41
CashflowEarnings quality: real cash, not paper profit
34
82
Fin. StrengthBalance sheet, leverage, solvency risk
74
100
InvestmentDisciplined investing over empire-building
36
27
Low VolatilityCalm price path (market factor)
69
78
MomentumPrice trend over the last 3–12 months (market factor)
23
35
52W MomentumDistance to the 52-week high (market factor)
30
29
Net IssuanceBuybacks instead of dilution
75
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Siegfried Holding

DCF ModelsCHF 45.80
Earnings-BasedCHF 31.53
Dividend DiscountCHF 6.12
MultiplesCHF 70.43
Asset-BasedCHF 17.25
Economic ProfitCHF 36.42
Growth EarningsCHF 76.56

20 of 23 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.78
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥23.65
Asset-Based¥6.44
Growth DCF¥39.88
Economic Profit¥18.21
Growth Earnings¥30.99

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Siegfried Holding
Bear CHF 26.18Fair Value CHF 52.72Bull CHF 91.25
CHF 79.65 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥54.62 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Siegfried Holding · Health Care

Quality score52 · above median
Fair value upside-34% · below median

Jiangsu Hengrui Medicine Co · Health Care

Quality score66 · Top 25%
Fair value upside-53% · below median

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Siegfried Holding as the less overvalued of the two: Siegfried Holding trades at CHF 79.65 versus a fair value of CHF 52.72 (-34%), while Jiangsu Hengrui Medicine Co trades at ¥54.62 versus ¥25.94 (-53%).

Jiangsu Hengrui Medicine Co has the higher quality score (66/100).

See the full analysis →
Siegfried Holding · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Siegfried Holding

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Jiangsu Hengrui Medicine Co

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.